Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates

BACKGROUND: Increasing numbers of immunocompromised patients have resulted in greater incidence of invasive fungal infections with high mortality. Candida albicans infections dominate, but during the last decade, Candida glabrata has become the second highest cause of candidemia in the United States...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Kari-Mette, Kristoffersen, Anne Karin, Ingebretsen, André, Vikholt, Katharina Johnsen, Örtengren, Ulf Thore, Olsen, Ingar, Enersen, Morten, Gaustad, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748091/
https://www.ncbi.nlm.nih.gov/pubmed/26861194
http://dx.doi.org/10.3402/jom.v8.29849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748091/
https://www.ncbi.nlm.nih.gov/pubmed/26861194
http://dx.doi.org/10.3402/jom.v8.29849

Ejemplares similares